Pune, India -- (SBWIRE) -- 06/12/2018 -- Global Molecular Imaging Market, By Types (Small molecules, Peptides, Engineered protein fragments, Aptamers, Nanoparticles and Others), By Application (Oncology, Cardiology, Gastrointestinal Disorders and Neurology Disorders), By End Users (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic & imaging centers and Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025
Get Free Sample of Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-molecular-imaging-market
Global Molecular Imaging Market is expected to reach USD 27.72 Billion by 2025, from USD 9.36 Billion in 2017 growing at a CAGR of 6.5% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2017, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Major Market Drivers and Restraints:
- Increase in functionality of products
- Increase in aging population suffering from end stage disease
- Widespread presence of cancer disorders
- Requirement of digitization and novel contrast agents
- Expensive investment
- Rapid pace of innovation limits spending and lack of awareness
Get Discount On This Report To Know More Mail Us @ Sopan.gedam@databridgemarketresearch.com
Competitive Analysis:
The global molecular imaging market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of molecular imaging market for global, Europe, North America, Asia Pacific and South America.
Major Market competitors/players:
- General Electric,
- Bracco Diagnostic Inc.,
- Guerbet,
- Eisai Pharmaceuticals India Pvt. Ltd.,
- CardiArc,
- Digirad Corporation,
- LumaGEM,
- Hitachi,
- Mediso Ltd.,
- CMR Naviscan,
- BC Technical,
- Toshiba India Pvt. Ltd,
- Trivitron Healthcare Ltd.
- NeuroLogica Corp.,
- Neusoft Corporation,
- Koninklijke Philips N.V,
- PerkinElmer Inc,
- Hamamatsu Photonics K.K.,
- Scintomics GmbH Kereos, Inc,
- Affibody Medical AB,
- among others.
Questions? We'll Put You on the Right Path Request Analyst Call @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-molecular-imaging-market
Market Segmentation:
- The global molecular imaging market is segmented on the basis of type, application, end users and geography.
- Based on type the market is segmented into Small molecules, Peptides, Engineered protein fragments, Aptamers, Nanoparticles and Others.
- Based on the application, the market is segmented into Oncology, Cardiology, Gastrointestinal Disorders and Neurology Disorders.
- On the basis of end users, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic & imaging centers and Others.
- Based on geography the global molecular imaging market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others
Browser Full Report With Research Methodology And Table Of Content @
http://databridgemarketresearch.com/reports/global-molecular-imaging-market/
If You Have Any Special Requirements, Please Let Us Know And We Will Offer You The Report As You Want.